Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2025-12-25 @ 9:27 PM
Study NCT ID:
NCT00789256
Status:
COMPLETED
Last Update Posted:
2018-10-24
First Post:
2008-10-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Low Dose Melphalan and Bortezomib for AML and High-Risk MDS
Sponsor:
Dartmouth-Hitchcock Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-09
Start Date Type:
None
Primary Completion Date:
2008-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-06
First Submit QC Date:
None
Study First Post Date:
2008-11-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-05-29
Results First Submit QC Date:
None
Results First Post Date:
2013-07-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-22
Last Update Post Date:
2018-10-24
Last Update Post Date Type:
ACTUAL